Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

342 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Neurodevelopmental outcomes of infants after in utero exposure to SARS-CoV-2 or mRNA-COVID-19 vaccine compared with unexposed infants: a COVI-PREG prospective cohort study.
Favre G, Bromley RL, Bluett-Duncan M, Maisonneuve E, Pomar L, Daire C, Radan AP, Raio L, Surbek D, Blume C, Kalimeris S, Madec Y, Schneider J, Bickle Graz M, Winterfeld U, Panchaud A, Baud D. Favre G, et al. Clin Microbiol Infect. 2024 Oct 23:S1198-743X(24)00501-9. doi: 10.1016/j.cmi.2024.10.019. Online ahead of print. Clin Microbiol Infect. 2024. PMID: 39454753
COVID-19 mRNA vaccine in pregnancy: Results of the Swiss COVI-PREG registry, an observational prospective cohort study.
Favre G, Maisonneuve E, Pomar L, Winterfeld U, Daire C, Martinez de Tejada B, Delecraz D, Campelo S, Moser M, Todesco-Bernasconi M, Sturm S, Hösli I, Monod C, Frey Tirri B, Kalimeris S, Blume C, Mathis J, Zimmerman R, Radan AP, Surbek D, Baud D, Panchaud A. Favre G, et al. Lancet Reg Health Eur. 2022 May 29;18:100410. doi: 10.1016/j.lanepe.2022.100410. eCollection 2022 Jul. Lancet Reg Health Eur. 2022. PMID: 35651954 Free PMC article.
Risk of congenital malformation after first trimester mRNA COVID-19 vaccine exposure in pregnancy: the COVI-PREG prospective cohort.
Favre G, Maisonneuve E, Pomar L, Daire C, Monod C, Martinez de Tejada B, Quibel T, Todesco-Bernasconi M, Sentilhes L, Blume C, Papadia A, Sturm S, Bassler D, Grawe C, Radan AP, Rossier MC, Mathis J, Capoccia-Brugger R, Lepigeon K, Gerbier E, Addor MC, Winterfeld U, Baud D, Panchaud A; COVI-PREG group. Favre G, et al. Clin Microbiol Infect. 2023 Oct;29(10):1306-1312. doi: 10.1016/j.cmi.2023.06.015. Epub 2023 Jun 19. Clin Microbiol Infect. 2023. PMID: 37343619 Free PMC article.
Guidelines for pregnant women with suspected SARS-CoV-2 infection.
Favre G, Pomar L, Qi X, Nielsen-Saines K, Musso D, Baud D. Favre G, et al. Lancet Infect Dis. 2020 Jun;20(6):652-653. doi: 10.1016/S1473-3099(20)30157-2. Epub 2020 Mar 3. Lancet Infect Dis. 2020. PMID: 32142639 Free PMC article. No abstract available.
SARS-CoV-2 ACE-receptor detection in the placenta throughout pregnancy.
Gengler C, Dubruc E, Favre G, Greub G, de Leval L, Baud D. Gengler C, et al. Among authors: favre g. Clin Microbiol Infect. 2021 Mar;27(3):489-490. doi: 10.1016/j.cmi.2020.09.049. Epub 2020 Oct 3. Clin Microbiol Infect. 2021. PMID: 33022363 Free PMC article. No abstract available.
COVID-19-related medicine utilization study in pregnancy: The COVI-PREG cohort.
Favre G, Gerbier E, Maisonneuve E, Pomar L, Winterfeld U, Lepigeon K, Bloemenkamp KWM, de Bruin O, Hurley E, Nordeng H, Siiskonen SJ, Sturkenboom MCJM, Baud D, Panchaud A; COVI-PREG and CONSIGN group. Favre G, et al. Br J Clin Pharmacol. 2023 May;89(5):1560-1574. doi: 10.1111/bcp.15611. Epub 2022 Dec 16. Br J Clin Pharmacol. 2023. PMID: 36417423 Free article.
342 results